Bluejay Diagnostics (BJDX)

• Market cap: $1.8M
• 1 day: -2.12%
• 5 days: -7.96%
• 1 month: -26.88%
• 3 months: -47.74%
• 6 months: -69.57%
• Year to date: -29.39%
• 1 year: -89.49%
• 5 years: -100%
• 10 years: -100%
• Sector: Healthcare
• Industry: Medical Devices

About: Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Employees: 6